First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...
Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...
Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback